Poseida raises $142 million in private financing round led by Novartis Pharma
DUBLIN: Malin Corporation plc., a company investing in highly innovative life sciences companies, notes that Poseida Therapeutics, one of Malin’s Priority Assets, has announced the closing of a Series C…